Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid

Virology

Volumn 405, Issue 1, 2010, Pages 20-25

  Pastrana, Diana V ^a   Pumphrey, Katherine A ^a   Çuburu, Nicolas ^a   Schowalter, Rachel M ^a   Buck, Christopher B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HPyV; MAb; MCPyV; MCV; Merkel Cell Carcinoma; Neutralization; Polyomavirus; PyV

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; PROTEIN VP1; PROTEIN VP2; VIRUS CAPSID ANTIGEN;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MERKEL CELL TUMOR; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; VIRUS CAPSID; VIRUS ENTRY; WART VIRUS;

MIRIDAE; POLYOMAVIRUS;

EID: 77955514047     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.022     Document Type: Article

References (42)

1. Agelli M., Clegg L.X. Epidemiology of primary Merkel cell carcinoma in the United States. J. Am. Acad. Dermatol. 2003, 49(5):832-841.
2. Becker J.C., Houben R., Ugurel S., Trefzer U., Pfohler C., Schrama D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol. 2008.
3. Bialasiewicz S., Lambert S.B., Whiley D.M., Nissen M.D., Sloots T.P. Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg. Infect. Dis. 2009, 15(3):492-494.
4. Buck C.B., Cheng N., Thompson C.D., Lowy D.R., Steven A.C., Schiller J.T., Trus B.L. Arrangement of L2 within the papillomavirus capsid. J. Virol. 2008, 82(11):5190-5197.
5. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 2004, 78(2):751-757.
6. Chong D.C., Raboni S.M., Abujamra K.B., Marani D.M., Nogueira M.B., Tsuchiya L.R., Neto H.J., Flizikowski F.B., de Noronha L. Respiratory viruses in pediatric necropsies: an immunohistochemical study. Pediatr. Dev. Pathol. 2009, 12(3):211-216.
7. Christensen N.D., Dillner J., Eklund C., Carter J.J., Wipf G.C., Reed C.A., Cladel N.M., Galloway D.A. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 1996, 223(1):174-184.
8. Christensen N.D., Kirnbauer R., Schiller J.T., Ghim S.J., Schlegel R., Jenson A.B., Kreider J.W. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 1994, 205(1):329-335.
9. Christensen N.D., Kreider J.W. Antibody-mediated neutralization in vivo of infectious papillomaviruses. J. Virol. 1990, 64(7):3151-3156.
10. Czajkowsky D.M., Shao Z. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(35):14960-14965.
11. Day P.M., Thompson C.D., Buck C.B., Pang Y.Y., Lowy D.R., Schiller J.T. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J. Virol. 2007, 81(16):8784-8792.
12. Engels E.A., Frisch M., Goedert J.J., Biggar R.J., Miller R.W. Merkel cell carcinoma and HIV infection. Lancet 2002, 359(9305):497-498.
13. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319(5866):1096-1100.
14. Fenwick F., Bassendine M.F., Agarwal K., Bevitt D., Pumeechockchai W., Burt A.D., Toms G.L. Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. J. Clin. Pathol. 2006, 59(2):174-178.
15. Forstova J., Krauzewicz N., Wallace S., Street A.J., Dilworth S.M., Beard S., Griffin B.E. Cooperation of structural proteins during late events in the life cycle of polyomavirus. J. Virol. 1993, 67(3):1405-1413.
16. Foulongne V., Dereure O., Kluger N., Moles J.P., Guillot B., Segondy M. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br. J. Dermatol. 2009.
17. Garneski K.M., Warcola A.H., Feng Q., Kiviat N.B., Leonard J.H., Nghiem P. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J. Invest. Dermatol.. 2008.
18. Goh S., Lindau C., Tiveljung-Lindell A., Allander T. Merkel cell polyomavirus in respiratory tract secretions. Emerg. Infect. Dis. 2009, 15(3):489-491.
19. Green N.M. Avidin. Adv. Protein Chem. 1975, 29:85-133.
20. Harris J.F., Hawley R.G., Hawley T.S., Crawford-Sharpe G.C. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6. J. Immunol. Meth. 1992, 148(1-2):199-207.
21. Jahn G., Harthus H.P., Broker M., Borisch B., Platzer B., Plachter B. Generation and application of a monoclonal antibody raised against a recombinant cytomegalovirus-specific polypeptide. Klin. Wochenschr. 1990, 68(20):1003-1007.
22. Kantola K., Sadeghi M., Lahtinen A., Koskenvuo M., Aaltonen L.M., Mottonen M., Rahiala J., Saarinen-Pihkala U., Riikonen P., Jartti T., Ruuskanen O., Soderlund-Venermo M., Hedman K. Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J. Clin. Virol. 2009, 45(4):292-295.
23. Karim N., Pallesen G. Epstein-Barr virus (EBV) and gastric carcinoma in Malaysian patients. Malays. J. Pathol. 2003, 25(1):45-47.
24. Klasse P.J., Sattentau Q.J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 2002, 83(Pt 9):2091-2108.
25. Lemos B., Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J. Invest. Dermatol. 2007, 127(9):2100-2103.
26. Loyo M., Guerrero-Preston R., Brait M., Hoque M., Chuang A., Kim M., Sharma R., Liegeois N., Koch W., Califano J., Westra W., Sidransky D. Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int. J. Cancer 2009.
27. Macagno A., Bernasconi N.L., Vanzetta F., Dander E., Sarasini A., Revello M.G., Gerna G., Sallusto F., Lanzavecchia A. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J. Virol. 2010, 84(2):1005-1013.
28. Morey A.L., O'Neill H.J., Coyle P.V., Fleming K.A. Immunohistological detection of human parvovirus B19 in formalin-fixed, paraffin-embedded tissues. J. Pathol. 1992, 166(2):105-108.
29. Nilson B.H., Logdberg L., Kastern W., Bjorck L., Akerstrom B. Purification of antibodies using protein L-binding framework structures in the light chain variable domain. J. Immunol. Meth. 1993, 164(1):33-40.
30. Norkin L.C., Anderson H.A., Wolfrom S.A., Oppenheim A. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 2002, 76(10):5156-5166.
31. Pastrana D.V., Tolstov Y.L., Becker J.C., Moore P.S., Chang Y., Buck C.B. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009, 5(9):e1000578.
32. Penn I., First M.R. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999, 68(11):1717-1721.
33. Portolani M., Tamassia M.G., Gennari W., Pecorari M., Beretti F., Alu M., Maiorana A., Migaldi M. Post-mortem diagnosis of encephalitis in a 75-year-old man associated with human herpesvirus-6 variant A. J. Med. Virol. 2005, 77(2):244-248.
34. Quan F.S., Sailaja G., Skountzou I., Huang C., Vzorov A., Compans R.W., Kang S.M. Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins. Vaccine 2007, 25(19):3841-3850.
35. Racine R., Winslow G.M. IgM in microbial infections: taken for granted?. Immunol. Lett. 2009, 125(2):79-85.
36. Roden R.B., Weissinger E.M., Henderson D.W., Booy F., Kirnbauer R., Mushinski J.F., Lowy D.R., Schiller J.T. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 1994, 68(11):7570-7574.
37. Roost H.P., Bachmann M.F., Haag A., Kalinke U., Pliska V., Hengartner H., Zinkernagel R.M. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(5):1257-1261.
38. Schiller J.T., Lowy D.R. Papillomavirus-like particle based vaccines: cervical cancer and beyond. Expert Opin. Biol. Ther. 2001, 1(4):571-581.
39. Senger T., Becker M.R., Schadlich L., Waterboer T., Gissmann L. Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses. J. Virol. 2009, 83(24):12692-12701.
40. Smith J.F., Kowalski R., Esser M.T., Brown M.J., Bryan J.T. Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11. Hum. Vaccin. 2008, 4(2):134-142.
41. Tolstov Y.L., Pastrana D.V., Feng H., Becker J.C., Jenkins F.J., Moschos S., Chang Y., Buck C.B., Moore P.S. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer 2009, 125(6):1250-1260.
42. Wieland U., Mauch C., Kreuter A., Krieg T., Pfister H. Merkel cell polyomavirus DNA in persons without Merkel cell carcinoma. Emerg. Infect. Dis. 2009, 15(9):1496-1498.